Insider trading

Period: 120 months Stock: STLN Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

115 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

115 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

115 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

115 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
115 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
115 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

115 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
14 Aug 2026
Chernett Jorey 10% owner
Bought
$78.48K 12,000 at 6.54
0.1%
21 Jul 2026
Chernett Jorey 10% owner
Bought
$94.86K 18,000 at 5.27
0.2%
10 Jul 2026
Chernett Jorey 10% owner
Bought
$87.75K 15,000 at 5.85
0.1%
23 Jun 2026
Chernett Jorey 10% owner
Bought
$90.36K 18,000 at 5.02
0.2%
4 Jun 2026
Chernett Jorey 10% owner
Bought
$57.00K 12,000 at 4.75
0.1%
20 May 2026
Chernett Jorey 10% owner
Bought
$136.35K 33,500 at 4.07
0.3%
19 May 2026
Chernett Jorey 10% owner
Bought 2×
$142.95K 35,000 at 4.08
0.3%
9 Apr 2026
Chernett Jorey 10% owner
Bought
$62.00K 20,000 at 3.10
0.2%
27 Mar 2026
Chernett Jorey 10% owner
Bought
$81.19K 27,429 at 2.96
0.3%
26 Mar 2026
Chernett Jorey 10% owner
Bought
$157.50K 50,000 at 3.15
0.5%
24 Mar 2026
Chernett Jorey 10% owner
Bought
$388.75K 125,000 at 3.11
1.2%
20 Mar 2026
Chernett Jorey 10% owner
Bought
$83.75K 25,000 at 3.35
0.2%
17 Mar 2026
Chernett Jorey 10% owner
Bought
$256.50K 75,000 at 3.42
0.7%
16 Mar 2026
Chernett Jorey 10% owner
Bought
$200.64K 60,985 at 3.29
0.6%
13 Mar 2026
Chernett Jorey 10% owner
Bought
$767.96K 263,000 at 2.92
2.7%
First buy on file
2 Jan 2026
Carter Robert Ross Chief Financial Officer
Sold at will
$879.32 247 at 3.56
0.1%
Not planned
15 Dec 2025
Hively Brad Director
Sold at will
$50.29K 13,333 at 3.77
1.9%
Not planned
18 Nov 2025
Pacala Mark L Director
Sold at will 3×
$200.00K 50,000 at 4.00
22.2%
Not planned
4 Sep 2025
Sold at will
$18.60M 6,018,168 at 3.09
43.1%
Not planned
4 Sep 2025
M33 Growth I L.P. Director · indirect
Sold at will
$2.11M 681,832 at 3.09
53.6%
Sold half or more
19 Aug 2025
Hively Brad Director
Sold at will
$82.10K 20,221 at 4.06
3.1%
Not planned
5 Jun 2025
Sold at will
$2.05M 673,676 at 3.05
4.6%
Not planned
5 Jun 2025
M33 Growth I L.P. Director · indirect
Sold at will
$232.79K 76,324 at 3.05
5.7%
Not planned
3 Jun 2025
Hively Brad Director
Sold at will 2×
$5.67M 1,976,137 at 2.87
76.6%
Sold half or more
20 May 2025
Sold at will
$4.87M 1,796,468 at 2.71
10.9%
Not planned
20 May 2025
M33 Growth I L.P. Director · indirect
Sold at will
$552.16K 203,532 at 2.71
13.1%
Not planned
26 Mar 2025
BARASCH RICHARD A Director · indirect
Bought
$1.42M 1,358,448 at 1.04
326%
Largest buy in 3 yrs
26 Mar 2025
Pacala Mark L Director · indirect
Bought
$94.34K 90,562 at 1.04
67.4%
First buy on file
26 Mar 2025
Bought
$37.73K 36,224 at 1.04
21.7%
First buy on file
26 Mar 2025
Virnich Daniel Chief Executive Officer
Bought
$23.58K 22,640 at 1.04
3.2%
First buy on file
26 Mar 2025
Castle Jeremy Chief Operating Officer
Bought
$9.43K 9,056 at 1.04
11.1%
First buy on file
26 Mar 2025
Podnos Yale Chief Medical Officer
Bought
$9.43K 9,056 at 1.04
12.9%
First buy on file
26 Mar 2025
Hively Brad Director
Bought
$9.43K 9,056 at 1.04
1.4%
26 Mar 2025
Carter Robert Ross Chief Financial Officer
Bought
$9.43K 9,056 at 1.04
29.8%
First buy on file
2 Dec 2024
Hively Brad Director
Bought
$7.50K 50,000 at 0.15
8.1%
26 Nov 2024
Hively Brad Director
Bought
$42.50K 250,000 at 0.17
68.2%
First buy on file
29 Jan 2024
Havencrest Healthcare Partners, L.P. 10% owner · indirect
Sold at will
$18.31K 8,637 at 2.12
100%
Sold half or more
26 Jan 2024
Havencrest Healthcare Partners, L.P. 10% owner · indirect
Sold at will
$14.94K 6,979 at 2.14
44.7%
Not planned
25 Jan 2024
Havencrest Healthcare Partners, L.P. 10% owner · indirect
Sold at will
$24.60K 11,882 at 2.07
43.2%
Not planned
24 Jan 2024
Havencrest Healthcare Partners, L.P. 10% owner · indirect
Sold at will
$57.30K 24,915 at 2.30
47.5%
Not planned
23 Jan 2024
Havencrest Healthcare Partners, L.P. 10% owner · indirect
Sold at will
$11.26K 5,338 at 2.11
9.2%
Not planned
22 Jan 2024
Havencrest Healthcare Partners, L.P. 10% owner · indirect
Sold at will
$21.76K 10,263 at 2.12
15.1%
Not planned
19 Jan 2024
Havencrest Healthcare Partners, L.P. 10% owner · indirect
Sold at will
$25.53K 11,986 at 2.13
15.0%
Not planned
14 Dec 2023
Shah Mihir Chief Financial Officer
Bought 2×
$126.99K 100,000 at 1.27
43.8%
First buy on file
17 Nov 2023
Hively Brad Director
Sold at will
$56.00K 25,000 at 2.24
3.5%
Not planned
13 Nov 2023
Hively Brad Director
Sold at will
$118.58K 47,000 at 2.52
6.1%
Not planned
17 Mar 2023
Bought 8×
$27.50K 50,000 at 0.55
24.1%
+24% of stake
16 Dec 2022
Miller Matthew P Chief Operating Officer
Bought
$70.00K 73,684 at 0.95
72.5%
First buy on file
14 Nov 2022
Kaushal Mohit Director
Sold, plan not stated
$34.08K 15,994 at 2.13
38.5%
11 Nov 2022
Havencrest Healthcare Partners, L.P. 10% owner · indirect
Sold, plan not stated
$851.20K 365,321 at 2.33
2.7%
Showing 1–50 of 115. Page 1 of 3 Older →